By Jim Hughes LRG Science Coordinator International AZD2171 Phase II: The AZD2171 Phase II Trial in the UK is now listed as “Not recruiting”. Dasatinib Phase II: This new trial for GIST is now open at Centre Hospitalier Universitaire Vaudois in Lausanne, Switzerland, CH-1011. Dasatinib (BMS- 354825) is approved for leukemia (CML). Dasatinib is a […]
The Latest News from the Life Raft Group